[
    {
        "title": "Super League Regains Compliance with Nasdaq Listing Requirements - Yahoo Finance",
        "description": "Super League Regains Compliance with Nasdaq Listing Requirements  Yahoo Finance",
        "published date": "Wed, 27 Sep 2023 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiVGh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9zdXBlci1sZWFndWUtcmVnYWlucy1jb21wbGlhbmNlLW5hc2RhcS0xMjAwMDA4ODAuaHRtbNIBXGh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vYW1waHRtbC9uZXdzL3N1cGVyLWxlYWd1ZS1yZWdhaW5zLWNvbXBsaWFuY2UtbmFzZGFxLTEyMDAwMDg4MC5odG1s?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1"
    },
    {
        "title": "Should Telecom Services Stock Altice USA Inc (ATUS) Be in Your Portfolio Wednesday? - InvestorsObserver",
        "description": "Should Telecom Services Stock Altice USA Inc (ATUS) Be in Your Portfolio Wednesday?  InvestorsObserver",
        "published date": "Wed, 27 Sep 2023 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMihAFodHRwczovL3d3dy5pbnZlc3RvcnNvYnNlcnZlci5jb20vbmV3cy9zdG9jay11cGRhdGUvc2hvdWxkLXRlbGVjb20tc2VydmljZXMtc3RvY2stYWx0aWNlLXVzYS1pbmMtYXR1cy1iZS1pbi15b3VyLXBvcnRmb2xpby13ZWRuZXNkYXnSAYgBaHR0cHM6Ly93d3cuaW52ZXN0b3Jzb2JzZXJ2ZXIuY29tL25ld3Mvc3RvY2stdXBkYXRlL2FtcC9zaG91bGQtdGVsZWNvbS1zZXJ2aWNlcy1zdG9jay1hbHRpY2UtdXNhLWluYy1hdHVzLWJlLWluLXlvdXItcG9ydGZvbGlvLXdlZG5lc2RheQ?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1"
    },
    {
        "title": "Is Warner Bros Discovery Inc (WBD) a Leader in the Entertainment Industry? - InvestorsObserver",
        "description": "Is Warner Bros Discovery Inc (WBD) a Leader in the Entertainment Industry?  InvestorsObserver",
        "published date": "Wed, 27 Sep 2023 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMie2h0dHBzOi8vd3d3LmludmVzdG9yc29ic2VydmVyLmNvbS9uZXdzL3N0b2NrLXVwZGF0ZS9pcy13YXJuZXItYnJvcy1kaXNjb3ZlcnktaW5jLXdiZC1hLWxlYWRlci1pbi10aGUtZW50ZXJ0YWlubWVudC1pbmR1c3RyedIBf2h0dHBzOi8vd3d3LmludmVzdG9yc29ic2VydmVyLmNvbS9uZXdzL3N0b2NrLXVwZGF0ZS9hbXAvaXMtd2FybmVyLWJyb3MtZGlzY292ZXJ5LWluYy13YmQtYS1sZWFkZXItaW4tdGhlLWVudGVydGFpbm1lbnQtaW5kdXN0cnk?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1"
    },
    {
        "title": "Fubotv Inc (FUBO) is up 0.84% Wednesday In Premarket Trading - InvestorsObserver",
        "description": "Fubotv Inc (FUBO) is up 0.84% Wednesday In Premarket Trading  InvestorsObserver",
        "published date": "Wed, 27 Sep 2023 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMibWh0dHBzOi8vd3d3LmludmVzdG9yc29ic2VydmVyLmNvbS9uZXdzL3N0b2NrLXVwZGF0ZS9mdWJvdHYtaW5jLWZ1Ym8taXMtdXAtMC04NC13ZWRuZXNkYXktaW4tcHJlbWFya2V0LXRyYWRpbmfSAXFodHRwczovL3d3dy5pbnZlc3RvcnNvYnNlcnZlci5jb20vbmV3cy9zdG9jay11cGRhdGUvYW1wL2Z1Ym90di1pbmMtZnViby1pcy11cC0wLTg0LXdlZG5lc2RheS1pbi1wcmVtYXJrZXQtdHJhZGluZw?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1"
    },
    {
        "title": "Duchenne Muscular Dystrophy Market to Propel at a Significant CAGR by 2032, Assesses DelveInsight | Key Companies - Pfizer, Santhera, Taiho, FibroGen, Sarepta, Capricor, Daiichi Sankyo, Solid Biosciences - Yahoo Finance",
        "description": "Duchenne Muscular Dystrophy Market to Propel at a Significant CAGR by 2032, Assesses DelveInsight | Key Companies - Pfizer, Santhera, Taiho, FibroGen, Sarepta, Capricor, Daiichi Sankyo, Solid Biosciences  Yahoo Finance",
        "published date": "Wed, 27 Sep 2023 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiV2h0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9kdWNoZW5uZS1tdXNjdWxhci1keXN0cm9waHktbWFya2V0LXByb3BlbC0xNzAwMDA3OTcuaHRtbNIBX2h0dHBzOi8vZmluYW5jZS55YWhvby5jb20vYW1waHRtbC9uZXdzL2R1Y2hlbm5lLW11c2N1bGFyLWR5c3Ryb3BoeS1tYXJrZXQtcHJvcGVsLTE3MDAwMDc5Ny5odG1s?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1"
    },
    {
        "title": "Endpoints News — Gilead stops another CD47 trial; Roche, Ionis ... - reports.endpts.com",
        "description": "Endpoints News — Gilead stops another CD47 trial; Roche, Ionis ...  reports.endpts.com",
        "published date": "Wed, 27 Sep 2023 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiQGh0dHBzOi8vcmVwb3J0cy5lbmRwdHMuY29tLzc5MTUzYWJjL2IyNDdlNjE1LzI2ODNjMzk0L2luZGV4Lmh0bWzSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1"
    },
    {
        "title": "Top grocery deals Sept. 27-Oct. 3 - WRAL News",
        "description": "Top grocery deals Sept. 27-Oct. 3  WRAL News",
        "published date": "Wed, 27 Sep 2023 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiRGh0dHBzOi8vd3d3LndyYWwuY29tL3N0b3J5L3RvcC1ncm9jZXJ5LWRlYWxzLXNlcHQtMjctb2N0LTMvMjEwNjY1NTkv0gEiaHR0cHM6Ly93d3cud3JhbC5jb20vYW1wLzIxMDY2NTU5Lw?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1"
    },
    {
        "title": "Gracell Biotechnologies Reports Updated Clinical Data for FasTCAR-T GC012F for High-Risk, Newly Diagnosed Multiple Myeloma, Demonstrating 100% Stringent Complete Response Rate - Yahoo Finance",
        "description": "Gracell Biotechnologies Reports Updated Clinical Data for FasTCAR-T GC012F for High-Risk, Newly Diagnosed Multiple Myeloma, Demonstrating 100% Stringent Complete Response Rate  Yahoo Finance",
        "published date": "Wed, 27 Sep 2023 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiXmh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9ncmFjZWxsLWJpb3RlY2hub2xvZ2llcy1yZXBvcnRzLXVwZGF0ZWQtY2xpbmljYWwtMTIzMDAwNzEyLmh0bWzSAWZodHRwczovL2ZpbmFuY2UueWFob28uY29tL2FtcGh0bWwvbmV3cy9ncmFjZWxsLWJpb3RlY2hub2xvZ2llcy1yZXBvcnRzLXVwZGF0ZWQtY2xpbmljYWwtMTIzMDAwNzEyLmh0bWw?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1"
    },
    {
        "title": "ATO spokesperson and LinkedIn star Tim Loh steps out of spotlight - SmartCompany",
        "description": "ATO spokesperson and LinkedIn star Tim Loh steps out of spotlight  SmartCompany",
        "published date": "Thu, 28 Sep 2023 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiXGh0dHBzOi8vd3d3LnNtYXJ0Y29tcGFueS5jb20uYXUvZmluYW5jZS90YXgvdGltLWxvaC1hdG8tYXVzdHJhbGlhbi10YXhhdGlvbi1vZmZpY2UtbGlua2VkaW4v0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1"
    }
]